Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 58,810,778
- Total 13F shares
- 71,107,852
- Share change
- +3,993,162
- Total reported value
- $2,314,610,833
- Put/Call ratio
- 245%
- Reported price per share
- $32.56
- Number of holders
- 196
- Value change
- +$131,278,501
- Number of buys
- 113
- Number of sells
- 78
Security identity
Holder snapshot
Report period
Q1 2026
Institutions
196
Top holders
10
STOK full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Ownership snapshot
Top reported holders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
RTW INVESTMENTS, LP
13D/G signal
RTW INVESTMENTS, LP
Evidence rows
15
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
13D/G row: RTW INVESTMENTS, LP
Showing 1-6 of 15 holder rows.
Rank 1 holder
RTW INVESTMENTS, LP
13D/G
13F
- Ownership
- 9.9%
- Position
- $208.23M
Rank 2 holder
FMR LLC
13F
13D/G
- Ownership
- 9.8%
- Position
- $177.77M
Rank 3 holder
Lynx1 Capital Management LP
13F
13D/G
- Ownership
- 8.1%
- Position
- $171.54M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13D/G
13F
Company
|
9.9%
|
$208,227,353
5,940,866 shares
|
+$22,110,697 | 31 Mar 2026 |
| FMR LLC |
13F
13D/G
Company
|
9.8%
from 13D/G
|
$177,773,201
5,600,920 shares
|
— | 31 Dec 2025 |
| Lynx1 Capital Management LP |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$171,544,353
5,404,674 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.8%
from 13D/G
|
$165,446,463
5,212,554 shares
|
— | 31 Dec 2025 |
| Redmile Group, LLC |
13D/G
13F
Company
|
6.7%
|
$145,952,406
4,164,120 shares
|
-$7,423,976 | 31 Mar 2026 |
| MORGAN STANLEY |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$112,555,054
3,546,158 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
196
Shares
71,107,852
Rows available
196
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
183
Q1 2026 holders
196
Holder diff
13
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend